Print

IncellDx, Inc. Receives North American Product Leadership Award in the Molecular Diagnostics Market From Frost & Sullivan  
7/19/2012 9:23:06 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--Frost & Sullivan (F&S), an international management consultancy that identifies best practices in research, will present IncellDx with a Leadership Award in the Molecular Diagnostics Market. F&S cited IncellDx’s newly launched cervical cancer testing methodology, HPV OncoTect®, as the company’s “greatest contribution” and the “gold standard for gynecological care.”
//-->